Your browser doesn't support javascript.
loading
Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitors.
Iijima, Toshie; Hosonuma, Soichiro; Kurai, Hidetaka; Kajitani, Hayato; Sakurai, Shintaro; Tomaru, Takuya; Jojima, Teruo; Usui, Isao; Aso, Yoshimasa.
Afiliação
  • Iijima T; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Hosonuma S; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Kurai H; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Kajitani H; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Sakurai S; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Tomaru T; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Jojima T; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Usui I; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Aso Y; Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan.
Int J Clin Pract ; 75(11): e14732, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34388297

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Simportadores / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Limite: Humans Idioma: En Revista: Int J Clin Pract Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Simportadores / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Limite: Humans Idioma: En Revista: Int J Clin Pract Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão